Research / Epitalon

Epitalon

Neuroprotective & Cognitive

← Back to Shop
Epitalon

Epitalon Research Information

Pineal Tetrapeptide

For Longevity & Cellular Health Research

⚠️ Important: This information is for educational and research purposes only. Always consult with a qualified healthcare professional before use.

πŸ”¬ What is Epitalon?

Epitalon (also known as Epithalon or Epithalone) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly, AEDG) developed based on the amino acid composition of Epithalamin, a bovine pineal gland extract [citation:1][citation:5]. It has been extensively studied for its geroprotective and neuroendocrine effects, resulting from antioxidant, neuroprotective, and antimutagenic properties [citation:1].

As a fully defined molecule with a molecular weight of 390.35 Da, Epitalon eliminates the batch-to-batch variability of natural extracts, making it ideal for rigorous quantitative studies [citation:5]. It is available in pen and freeze-dried vial formulations for research purposes.

⚑ How Epitalon Works

Epitalon works through multiple mechanisms to support cellular health and longevity:

🧬

Telomerase Activation

Upregulates hTERT expression, leading to dose-dependent telomere elongation in human cell lines [citation:5]

πŸ›‘οΈ

Antioxidant Effects

Reduces ROS levels and restores wound healing by inhibiting hyperglycemia-induced fibrosis [citation:2][citation:9]

πŸ”„

Pineal Regulation

Restores melatonin secretion patterns and circadian rhythms in aging models [citation:7]

Epitalon also modulates mRNA levels of interleukin-2 and enhances the activity of various enzymes, including telomerase and acetylcholinesterases [citation:1]. Its geroprotector effects occur at concentrations 16,000 to 80,000,000 times lower than those of melatonin in Drosophila models [citation:10].

πŸ“‹ Research Applications

🧬

Longevity Research

Studied for lifespan extension (11-16% in Drosophila) and telomere maintenance [citation:5][citation:10]

πŸŒ™

Sleep & Circadian Rhythm

Restores melatonin secretion and sleep architecture in older adults [citation:7]

πŸ‘οΈ

Retinal Health

90% positive clinical effect in retinal degeneration; enhances wound healing in diabetic models [citation:2][citation:4]

βš•οΈ

Immune Function

Modulates T-lymphocyte development and improves immune system function in aging [citation:1]

πŸ“Š Clinical Studies

Retinitis Pigmentosa Clinical Trial (Neuroendocrinology Letters 2002)

  • Epitalon therapy in patients with degenerative retinal lesions resulted in a positive clinical effect in 90% of cases [citation:4]
  • Application of Epitalon intensified the bioelectric and functional activity of the retina due to preservation of its morphological structure [citation:4]

Lifespan Extension (Drosophila melanogaster)

  • Epitalon significantly increased lifespan by 11-16% at concentrations as low as 0.001Γ—10⁻⁢ wt.% [citation:10]
  • Effective concentrations were 16,000 to 80,000,000 times lower than those of melatonin [citation:10]
  • Geroprotector effect was almost independent of substance concentration within the tested range [citation:10]

Wound Healing & Diabetic Retinopathy (Stem Cell Reviews and Reports 2025)

  • Epitalon restored impaired wound healing in high glucose-injured retinal cells [citation:2]
  • At concentrations of 20, 40, and 60 ng/mL, it inhibited hyperglycemia-induced epithelial-mesenchymal transition and fibrosis [citation:9]
  • Reduced intracellular ROS levels and increased antioxidant gene expression [citation:2]

Telomere Elongation in Human Cells (2025)

  • Epitalon treatment resulted in dose-dependent telomere elongation in normal epithelial and fibroblast cells [citation:5]
  • Linked directly to hTERT mRNA upregulation and telomerase enzyme activity [citation:5]

Evidence Status

  • Most clinical research originates from Russia and Eastern Europe [citation:7]
  • Western peer-reviewed RCTs are limited; the peptide has not received FDA approval [citation:7][citation:11]
  • Telomerase activation carries a theoretical cancer risk (telomerase is upregulated in ~90% of cancers) [citation:11]

πŸ’‰ Interactive Dosing Guide

Select your vial size and dose to see the corresponding volume, clicks, dosing frequency, and how many doses per vial:

πŸ–ŠοΈ Step 1: Select Your Vial Size

πŸ’Š Step 2: Select Your Dose

Common research protocols: 5-10 mg per day for 20-day cycles [citation:7]. Animal studies used 1.0 Β΅g/mouse (30-40 Β΅g/kg) [citation:6].

Vial Size

50mg Vial

Selected Dose

5 mg

Doses per Vial

10 doses

Pen Clicks

30 clicks

Volume

0.30 mL

Protocol Level

Level 1 (Starting)

Recommended Schedule

Daily for 20 days - Loading Phase

⚠️ Do not change your dose unless advised by a qualified professional.

πŸ“‹ Protocol Level Summary

Based on research protocols: 5-15 mg daily for 20-day cycles, repeated every 3-6 months [citation:7].

Protocol Level Target Dose Frequency Pen Clicks Volume (mL) Who It\'s For
Level 1 (Starting) 5 mg Daily 30 clicks 0.30 mL New users, first 20-day cycle
Level 2 (Standard) 7.5-10 mg Daily 45-60 clicks 0.45-0.60 mL Standard protocol
Level 3 (Advanced) 12.5 mg Daily 75 clicks 0.75 mL If more response needed
Level 4 (Maximum) 15 mg Daily 90 clicks 0.90 mL Experienced users only

⚠️ Do not change your dose unless advised by a qualified professional.

πŸ’‰ Vial Users (Insulin Syringe)

Add 3mL of bacteriostatic water to your freeze-dried vial and mix gently. After reconstitution, use the table below to draw your dose:

Vial Size

50mg vial with 3mL bac water

Dose Frequency Units on Syringe Volume (mL) Protocol Level

⚠️ Always use a new sterile needle and syringe for each injection.

⚠️ Safety & Precautions

Reported side effects are generally mild (injection-site reactions, occasional drowsiness). However, long-term human safety data is limited [citation:7].

  • Injection site reactions: Mild redness or tenderness at injection site
  • Drowsiness: Occasional, reported in clinical use [citation:7]
  • Telomerase activation concern: Theoretical cancer risk; telomerase is upregulated in ~90% of cancers [citation:11]

Important Safety Considerations:

  • Epitalon is not FDA-approved for any indication [citation:7]
  • Most clinical research is from Russia and Eastern Europe; Western evidence is limited [citation:7][citation:11]
  • Contraindicated in patients with active malignancy, severe endocrine disorders, or known peptide hypersensitivity [citation:7]
  • Do not use if pregnant or breastfeeding [citation:7]
  • Quality control of commercially available Epitalon is variable [citation:11]

⚠️ Warning: Epitalon is an investigational peptide with limited human safety data. Telomerase activation carries a theoretical cancer risk. If you experience severe allergic reactions, difficulty breathing, or signs of anaphylaxis, seek immediate medical help.

πŸ“š References

  • Overview of Epitalonβ€”Highly Bioactive Pineal Tetrapeptide with Promising Properties. Dimensions. [citation:1]
  • The Antioxidant Tetrapeptide Epitalon Enhances Delayed Wound Healing in an in Vitro Model of Diabetic Retinopathy. Stem Cell Reviews and Reports. 2025;21(6):1822-1834. [citation:2]
  • Pineal-regulating tetrapeptide epitalon improves eye retina condition in retinitis pigmentosa. Neuroendocrinology Letters. 2002;23(4):365-368. [citation:4]
  • Epitalon Technical Guide. Benchchem. [citation:5]
  • Epitalon Peptide Therapy. Menscape Clinic. 2026. [citation:7]
  • Effect of epitalon on the lifespan increase in Drosophila melanogaster. Mechanisms of Ageing and Development. 2000;120(1-3):51-60. [citation:10]
  • Epitalon Peptide Evidence Score. Biomeme. [citation:11]

This information is for educational and research purposes only. Always consult with a qualified healthcare professional.

Last updated: July 2026

⚠️ FOR RESEARCH PURPOSES ONLY